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Abstract: Kyrgyzstan reported 77.5 new human brucellosis cases per 100,000 people in 2007, which is one of the
highest incidences worldwide. In Kyrgyzstan, the currently used diagnostic tests in humans and animals are the
Rose Bengal Test and the Huddleson test. A national representative cross-sectional study using cluster sampling
proportional to size in humans, cattle, sheep, and goats was undertaken to assess the apparent seroprevalence in
humans and animals. A total of 4,936 livestock sera and 1,774 human sera were tested in Naryn, Chuy, and Osh
Oblasts. The overall apparent seroprevalences of brucellosis were 8.8% in humans (95% CI 4.5–16.5), 2.8%
(95% CI 1.6–4.9%) in cattle, 3.3% (95% CI 1.5–6.9%) in sheep, and 2.5% (95% CI 1.4–4.5%) in goats. Naryn
Oblast had the highest seroprevalences in humans and sheep. More men than women were seropositive
(OR = 1.96; P < 0.001). Human seroprevalence was significantly associated with small ruminant seropreva-
lence but not with cattle seroprevalence. Annual incidence of human brucellosis exposure, measured by sero-
logical tests, was more than ten times higher than the annual incidence of reported clinical brucellosis cases. This
indicates an under-reporting of human brucellosis cases, even if only a fraction of seropositive people have
clinical symptoms. In conclusion, this study confirms the high seroprevalence of brucellosis in Kyrgyzstan and
warrants rapid effective intervention, among others, by mass vaccination of sheep and goats but also of cattle.
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INTRODUCTION
Brucellosis is a bacterial disease of livestock with a high
zoonotic potential. Its transmission from livestock to hu-
mans occurs mainly by consumption of raw dairy products
and by direct contact during delivery and abortion. Brucella
abortus is mainly found in cattle and B. melitensis and B.
ovis in goats and sheep. Humans are susceptible to both B.
abortus and B. melitensis, the latter being most frequently
reported in humans (Corbel 2006).
Brucellosis occurs worldwide, particularly in developing
and transition countries, but it is well controlled in indus-
trialised countries. Kyrgyzstan has one of the highest bru-
cellosis incidences worldwide with 36 reported annual
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human cases per 100,000 people in 2002 (Pappas et al. 2006),
and 77.5 per 100,000 people in 2007 (promedmail.org, Ar-
chive Number 20090201.0449, published Feb 1, 2009).
However, it is not known if the Kyrgyz health system
coverage is exhaustive and if all patients have access to care.
It is likely that the true incidence is underestimated. An
earlier study by Kozukeev et al. (2006) indicated the
importance of cattle for the transmission of brucellosis in
Kyrgyzstan, but the role of small ruminants for the trans-
mission of brucellosis in humans is not clear. Brucellosis can
be diagnosed by isolation (culture) of the bacteria, direct
PCR of Brucella spp. genome in contaminated specimens or
indirectly by antibody detection either in serum or milk
(Corbel 2006). The culturing of Brucella spp. from animal
samples is complex and dangerous and requires biosafety
level 3, which is not currently available in Kyrgyzstan.
Hence, we rely on available and more recent serological
methods for diagnosis. The objective of this study was to
assess representative brucellosis seroprevalences of livestock
and humans for Kyrgyzstan and the association between
human and livestock brucellosis seroprevalence. Represen-
tative estimates should be related to official reports and
inform Kyrgyz public health and veterinary policy. The test
characteristics of the Huddleson test in humans and Rose
Bengal Test in livestock, which are currently used in
Kyrgyzstan, are not known and there is no gold standard.
MATERIALS AND METHODS
Partnership Between Public Health
and the Veterinary Sector
In the Fall of 2006, an integrated assessment of human and
livestock brucellosis seroprevalence was undertaken jointly
by the Republican State Center for Veterinary Diagnostics,
the Republican Centre for Quarantine and especially dan-
gerous diseases, the State Sanitary Epidemiological Depart-
ment of the Kyrgyz Republic and the Swiss Tropical
and Public Health Institute. Complementary Support of
Community Action for Health facilitated this partnership
(Zinsstag et al. 2009).
Study Design
For this survey, the national census data on sheep and goat
populations was used. A multistage cluster sampling pro-
portional to size was determined by levels of Oblast
(province), Rayon (district), and village (Bennett et al. 1991;
Schelling et al. 2003). Three out of seven Oblasts were sam-
pled. Naryn Oblast was selected by convenience (availability
of previous serological studies), and the two others were
sampled randomly in proportion to their size. In every
Oblast, three Rayons, and in every Rayon, ten villages, were
selected randomly in proportion to their size as shown in
Fig. 1 (Bennett et al. 1991). In this way, a total of 90 villages
were selected randomly and used as cluster units. We
assumed an intraclass correlation roh of 0.2 between clusters
and a design effect of 4.8. Sampling of 20 humans or livestock
in every cluster provided a total sample size of 1,800 per
species and 95% confidence limits of the estimate of <3%
below and above the estimated seroprevalence, which is
representative for the whole country.
This study was approved by the Ethical committee of
the Cantons of Basel and the Kyrgyz Health Authorities.
Informed written consent was provided by all persons
participating in the study or of young children’s mothers,
after they had received detailed patient information.
Overall, the proportion of sheep to goats was estimated at
6:1. Due to the lack of more detailed information, we as-
sumed that this proportion is true for all Rayons. In the
year of study (2006) very few animals were vaccinated
against brucellosis in Kyrgyzstan and their influence on the
serological results of this study were considered negligible.
Human and Livestock Sample Collection
The study was conducted by three field teams composed of
one veterinarian and one physician in the spring of 2006. A
total of 103 villages in the nine selected Rayons were visited.
Venous blood was taken with 5 ml Vacutainer tubes and
the age, sex, and names were recorded for all participants.
Blood of livestock (cattle, sheep, and goats) was obtained by
venipuncture with 10 ml Vacutainer tubes. Livestock and
human samples were not necessarily collected from the
same households as the participation was voluntary. Human
blood was transported to the Rayon Health Center and
animal blood was transported to the Veterinary laboratory
and centrifuged. All sera were shipped to Bishkek either to
the Centre for Quarantine for testing of human sera with the
Huddleson agglutination test or to the Central Veterinary
Laboratory in Bishkek for other tests described below.
Diagnostic Tests
In Kyrgyzstan, the most common test is the Huddleson
agglutination test for humans (official test) and the Rose
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Bengal Test (RBT) for animals. Human sera were subjected
to the Huddleson test, the RBT (Bio-Rad Laboratories),
and an IgG and IgM ELISA (Chekit IDEXX Laboratories
Inc.) with anti-human-goat IgG and anti-human-goat IgM
conjugates (Sigma-Aldrich Co). The latter IgM test was
only done for sera that were Huddleson test or RBT posi-
tive and IgG ELISA negative. Classification of the ELISA
was then positive if either the IgG ELISA and/or the IgM
ELISA were positive. Livestock sera was tested with a RBT
from the Kherson Bio-Factory, Ukraine, an indirect ELISA
for ruminants (Checkit IDEXX Laboratories Inc.) and the
Fluorescence polarization assay (FPA) (Brucella FPA,
Diachemix, LLC). Tubes of 2 ml of sera were kept for
further testing and parallel tested in the Rayon veterinary
laboratory with the RBT.
Serological test results were interpreted according to
the manufacturers’ recommendations. Cut-off values were
determined by a titration curve analogous to Bonfoh and
Steinmann (Bonfoh et al. 2002; Steinmann et al. 2005).
With the exception of the FPA, all values were recorded as
negative, doubtful, and positive. The cut-off value of the
FPA was at 90 mP. Since, agreements of pair wise com-
parison of tests (Kappa statistics) within species were
generally better when all doubtful results were classified
negative than as positives, for binary classification of
results, doubtful sera were classified as negative for all tests,
although the best agreement between two serological tests
was only a moderate agreement (Kappa < 0.6). For live-
stock sera, agreements between tests were better for cattle
than for sheep and goats. For further statistical analyses, we
used the Huddleson agglutination test for human sera and
the ELISA results for livestock sera.
Data Analysis
Serological results were converted into dichotomous out-
comes (1 = seropositive, 0 = seronegative), depending on
the cut-off value of each test. Logistic regression, modeling
for the outcome of seropositive humans and livestock (SP)
included random effects (re) at various levels as follows: (1)
at the level of rayon for the national representative estimate
and for Oblast level, SP * re(Rayon) (Table 2). (2) For
the analysis of human sera the level of village was used as
random effect. Univariable models related SP individually
with sex, age, and Oblast (Table 3). (3) Assessing a possible
relationship between human and livestock seropositivity we
have regressed SP * proportions of human and livestock
seropositivity at rayon level (Table 4).
Analyses of Human Sera
Participants with the same family name within a village were
regrouped in a unique family code. Age in years
was categorized in steps of 10 years (0–10 years up to
Figure 1. Map of Kyrgyzstan with selected Oblasts and Rayons. Light gray Rayons belong to selected Oblasts but not selected Rayons, dark gray
rayon are the nine in this study selected Rayons (oblast = region and rayon = district).
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80–90 years) and in three categories that represent the life
stage: 0–18 years; 19–45 years; and 46 years. A unique
code was created for all villages. We have tested if age, sex, and
Oblast were associated with seropositivity in humans using a
logistic regression model (with a random effect at the village
level) based on the likelihood-ratio test (LRT) (xtlogit pro-
cedure in STATA 10). The variances of the Huddleson test
(humans) and ELISA (livestock) were highest at the Rayon
level (district) when compared to the levels of family, village,
and Oblast (province). For the logistic regression of human
sera, we considered village as a random effect. Age, sex, and
Oblast were tested as univariable variables. The LRT test was
used to test the significance of a variable (Table 3). Apparent
seroprevalences are presented, because the test characteristics
were not known for the different species.
Correlation Between Human and Livestock
Seropositivity
Regressions have been done with SP * proportions of
human and livestock seropositivity (all livestock, small
ruminants [sheep and goats together] and the single species
cattle, sheep, and goats) at rayon level. Not more than one
livestock category was tested in a model due to strong
correlation between sheep and goat seropositivity on Rayon
level. The confidence intervals were constructed using a
bootstrap re-sampling technique and the information on
total number of individuals tested per rayon.
Estimation of Incidence of Apparent Brucellosis
Seropositivity in Humans
The age-specific apparent seroprevalence of the Huddleson
tests was used to estimate the incidence of brucellosis
seropositivity of a catalytic two way model under equilib-
rium conditions (Muench 1959). We used data between the
2nd and 8th decade of life because data on younger or older
patients were too sparse.
dS=dt ¼ aS þ bI ð1Þ
dI=dt ¼ aS  bI; ð2Þ
where S is the susceptible population and I is the sero-
positive population. The parameter a is the incidence of
seroconversion and b the rate of loss of sero-positivity.
Under equilibrium conditions the apparent seroprevalence
P is related to a and b (Eq. 3).
P ¼ a= a þ bð Þ: ð3Þ
We estimated the seroconversion rate a and the loss
rate b simultaneously from the data using Vensim (Ventana
Inc.) software, using a Powell algorithm analogous to
(Zinsstag et al. 2005).
RESULTS
A total of 4,936 different livestock sera (1659, 1642, 1635
from Naryn, Chuy, and Osh Oblast, respectively) and a
total of 1,774 human sera (564, 606 and 604 from Naryn,
Chuy, and Osh Oblast, respectively) were tested with at
least one serological test (Table 1).
Representative Apparent Seroprevalences
and Human Incidences
In Table 2, human and livestock seroprevalences are pre-
sented for every Oblast. The highest human brucellosis
seroprevalence is found in Naryn Oblast and the lowest in
Table 1. Total sample size by species and number of samples examined with different diagnostic tests
Species Total RBT
(Biorad)a
RBT
(Ukraine)b
ELISA
(ruminant)c
ELISA IgG
(human)d
ELISA IgM
(human)d
FPAe Huddlesonf
Cattle 1,813 737 1,560 1,698 0 0 1,691 0
Sheep 2,076 761 1,855 2,029 0 0 2,029 0
Goats 1,286 764 1,082 1,209 0 0 1,176 0
Humans 1,775 644 0 0 1,762 369 0 1,774
aRose-Bengal Biorad.
bRose-Bengal Ukraine.
cIndirect enzyme-linked immunosorbent assay detecting IgG in ruminants.
dIndirect enzyme-linked immunosorbent assay detecting IgG and IgM, respectively, in humans.
eFluorescence polarization assay.
fHuddleson test.
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Osh Oblast. Using Rayon as a random effect, the overall
representative apparent seroprevalences of brucellosis for
Kyrgyzstan were 8.8% in humans (95% CI 4.5–16.5),
2.8% (95% CI 1.6–4.9%) in cattle, 3.3% (95% CI 1.5–
6.9%) in sheep, and 2.5% (95% CI 1.4–4.5%) in goats.
The average duration of brucellosis seropositivity (1/b)
was estimated at 10.9 years. Keeping this constant, human
incidence of apparent sero-conversion is estimated at
0.88% (95% CI 0.43–1.77%) per year for the Huddleson
test. This means that on average 880 (95% CI 400–1,770)
persons per 100,000 are exposed to brucellosis per year.
Extrapolated to the total Kyrgyz population of 5.2 mil-
lions on average 45,882 persons per year get exposed to
brucellosis.
Analysis of Human Sera for Risk Factors
of Brucellosis Seropositivity
Additional data on age, sex, and village was available for
1,761 people. The proportion of sampled female partici-
pants varied between 0.42 and 0.78 in the 9 Rayons and was
0.57 over the whole sample. The median age was 39 years
(5–95% percentiles 17–66). More male participants were
seropositive compared to females (in all three age classes)
(OR = 1.96; p(LRT) < 0.001) (Table 3).
Correlation Between Human
and Livestock Seropositivity
On the Rayon level, both pooled small ruminant and sheep
seroprevalences were correlated positively with human se-
roprevalences: an increase of 1% of small ruminant and
sheep seroprevalences, increased human seroprevalence by
0.97 and 0.83%, respectively (Table 4).
DISCUSSION
This study was designed as a representative cross-sectional
assessment of brucellosis prevalence in humans and live-
stock in Kyrgyzstan in 2006. Because of the highly endemic
epidemiological situation, the true incidence of clinical
brucellosis cannot be stated. The estimated incidence of
Table 2. Apparent seroprevalence estimates of brucellosis in
Kyrgyzstan for humans, cattle, sheep, and goats per oblast, 2006
Oblast species n Seroprevalencea 95% CI
Naryn Oblast
Humans 564 18.3 14.0–23.7
Cattle 536 2.2 0.8–6.0
Sheep 562 8.9 5.8–13.5
Goats 561 2.5 0.9–7.0
Chuy Oblast
Humans 606 8.9 6.9–11.5
Cattle 598 5.7 4.1–7.9
Sheep 610 3.0 0.0–9.7
Goats 434 2.7 1.3–5.7
Osh Oblast
Humans 604 2.2 0.1–27.6
Cattle 564 1.6 0.5–4.5
Sheep 857 1.3 0.4–3.9
Goats 214 2.8 1.3–6.1
aSeroprevalences (and 95% CI) calculated with a logistic regression model
specifying Rayon as a random effect.
Table 3. Risk factors of human seropositivity determined with
the Huddleson test as outcome variable
Variable Huddleson test Univariable logistic
regression model
n Pos% OR p(LRT)
Sex
Female 1,011 8.4 1 <0.001
Male 750 14.9 1.96 (1.4–2.7)
Age category
0–18 128 14.1 1 0.60
19–45 1,049 11.7 1.2 (0.6–2.3)
>45 584 9.6 1.03 (0.5–2)
Oblast
Naryn 560 18.4 1 <0.001
Chuy 600 8.3 0.4 (0.2–0.7)
Osh 601 7.3 0.2 (0.1–0.5)
The uni- and multivariable models used a random effect on village level.
P values of the log LRT are presented.
Table 4. Regression coefficients for human seropositivity and
livestock seropositivity
Intercept (95% CI) Slope (95% CI)
All livestock species 0.09 (0.05–0.12) 0.81 (-0.1 to 1.7)
Small ruminants 0.08 (0.05–0.11) 0.97 (0.3 to 1.7)
Cattle 0.15 (0.11–0.18) -0.88 (-1.8 to 0.2)
Sheep 0.07 (0.05–0.10) 0.83 (0.3 to 1.4)
Goats 0.09 (0.07–0.12) 0.99 (-0.06 to 2.1)
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apparent seropositivity using the Huddleson test of 880
(95% CI 400–1,770) per 100,000 is 11 times higher than the
officially reported number of brucellosis cases. There is no
data available in the literature indicating the proportion of
seroconversion that leads to clinically manifested brucel-
losis in endemic areas. If 10% of the people that serocon-
verted showed clinical symptoms, the incidence of clinical
brucellosis would be in agreement with the reported data.
However, if 50% of the people that seroconverted showed
clinical symptoms, the level of under-reporting would be
5.6 (95% CI 2.5–11.4). Studies in Saudi Arabia indicate a
high proportion of clinical illness among seropositive
family members of acute brucellosis cases (Almuneef et al.
2004; Alsubaie et al. 2005). Further studies are needed to
assess the true incidence of human cases. The estimated
duration of seropositivity of 10.9 years is in agreement with
Beklemishev in Kazakhstan (cited by v.Oldershausen 1968),
but we were not able to estimate a confidence limit, with-
out time series data.
In our study, the apparent seroprevalences between the
Oblasts ranged from 2.2 to 18.3% in humans and between
1.3 and 8.9% in livestock species with the highest variance
for both on the Rayon level. Although, the Oblast sero-
prevalences of the three livestock species were comparable,
we have seen a significant correlation between human and
small ruminant seropositivity on the Rayon level, thus
suggesting Rayon specific clustering. This likely reflects the
relatively localized contact networks and marketing system
of Kyrgyz livestock. A sheep–cattle relationship has been
confirmed by the detection of a B. melitensis strains in
sheep and in two cattle (data not shown). In humans, male
participants were more frequently seropositive than female
participants but no difference between age classes was de-
tected. More data is needed to understand the frequency of
brucellosis in children, where transmission may be due to
both direct exposure to contaminated livestock material
and consumption of raw livestock products. The higher risk
of male seropositivity in human adults indicates that
exposure in these rural villages may more likely be due to
direct (professional) close contact with infected livestock,
than by exposure through contaminated livestock products,
but this hypothesis requires further investigation. In a study
about risk factors of human brucellosis in Kyrgyzstan,
Kozukeev et al. (2006) reported a higher, however both non
significant, odds ratio (OR) for keeping cattle (adj.
OR = 4.5) followed by goats (adj. OR = 1.6). However, we
find no correlation between cattle and human seroposi-
tivity (indeed, we found a negative correlation) and we only
find a significant correlation with sheep, but not for goats.
Such contradictory results, also due to different study de-
signs, reflect the difficulty in determining an association of
infection between humans and animals for zoonotic dis-
eases. Confirmation of transmission chains by molecular
analysis of strains isolated from humans and different
livestock species is warranted.
This study was intended to inform Kyrgyz policy on
brucellosis epidemiology by providing representative data
using existing and new diagnostic tests. As it is important
to adapt assessments to local health policy decision path-
ways (Habicht et al. 1999), our analysis of human apparent
seroprevalence is based on the Huddleson agglutination
test, which is the officially recognized diagnostic test in
Kyrgyzstan.
In a complementary analysis, we assess the test char-
acteristics of all used tests using a Bayesian model for the
estimation of true seroprevalence in the absence of a gold
standard, which are published separately. The results will be
further used to estimate the cost of brucellosis to the
Kyrgyz economy analogous to Roth et al. (2003).
The presented study is an example of an integrated
human and animal study design under a ‘‘One Health’’
paradigm, facilitating identification of the source of a
zoonosis in the animal reservoir in a single step because of a
connected study design and the ability to assess the impact
of the disease in multiple sectors, notably the health and
livestock production sectors. It is thus an example of the
added value of a closer cooperation between human and
animal health practitioners (Zinsstag et al. 2009).
CONCLUSION
Our study confirms the high seroprevalence of brucellosis
in Kyrgyzstan and suggests that the annual incidence of
human brucellosis exposure, measured by serological tests,
is more than ten times higher than the annual incidence of
reported clinical brucellosis cases. This indicates an
underreporting of human brucellosis cases even if only a
fraction of the seropositive persons have clinical symptoms.
Human brucellosis seroprevalence was most closely asso-
ciated with brucellosis seroprevalence in sheep. Effective
mass vaccination of sheep, goats, and cattle, following the
guidelines by the World Animal Health Organization (OIE)
are warranted to control human brucellosis at its source.
Further research is needed to further confirm the human–
livestock linkages by molecular typing of brucella strains
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from humans and livestock, to relate human Brucellosis
seropositivity and clinical symptoms in a highly endemic
area like Kyrgyzstan and to monitor control policies for
their effectiveness.
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